India: Central Tuberculosis (TB) Division Releases FAQs On Mandatory TB Notification For Chemists/Pharmacies

The Ministry of Health and Family Welfare (MoH&FW), on March 16, 2018, has notified that tuberculosis is a dangerous epidemic disease, a threat to life and is a major public health problem accounting for substantial morbidity and mortality in the country. Early diagnosis and complete treatment of tuberculosis is the cornerstone of tuberculosis prevention and control strategy. Further, inappropriate diagnosis and irregular or incomplete treatment with anti-tubercular drugs may contribute to complications, spread of disease and emergence of drug-resistant tuberculosis.

However, the said notice also announced mandatory TB reporting measures, where all health care providers treating TB patients, and all pharmacies/chemists/druggists dispensing anti-tubercular medicines, shall notify every TB case they find and treat, to the public health departments. The notification further suggested patients to self-notify themselves with their own details and that of treating medical practitioners6.

On June 13, 2018, the Central Tuberculosis (TB) division has released Frequently Asked Questions (FAQs) on mandatory TB notification for easy reporting practice for Chemists/ Pharmacies7:

Is online submission of information mandatory for pharmacies/chemists & druggists?

Submission of information is mandatory; either electronically (online) or in hard copy (paper based). Modalities of reporting of information can be any of the following:

  • Hard copy by post, courier or by hand to the nodal officer
  • Electronic copy by email from persons / institutes authorized for this purpose to the nodal officer
  • Uploading of information directly on to the Nikshay portal -
  • Using authorized mobile numbers by phone call on 1800 11 6666
  • Direct online information transmission from laboratory or hospital MIS to NIKSHAY

The patient or his relative does not want to disclose their name & identity. How to notify such TB patients?

It is estimated that a TB patient, if left untreated, can spread the infection to at least 10-15 persons in a year. Hence, in case of TB, the concerned public health authorities should be informed immediately. Moreover, the information remains secured within the TB Notification system – NIKSHAY of the Government of India. Only authorized users of Nikshay, on behalf of 'Revised National TB Control Program (RNTCP), will have access to the information on patient for ensuring public health measures (to support TB patients in ensuring cure from the disease and prevent spread of the disease) as mentioned in section 5 of the Gazette. The information will not be shared outside the RNTCP and health officials. Confidentiality of the data gathered will be ensured as per EHR/ EMR standards and IT Act 2000 of Government of India & its amendment 2008.

Patient and their relatives are not ready to provide detailed residential address, their ID & Mobile or Telephone Number. How to provide this information in such instances?

TB is a communicable disease and it is estimated that, if left untreated, a TB patient can spread the infection to at least 10-15 persons in a year. Hence, TB patients should be treated at the earliest and certain public health measures like contact investigation, chemoprophylaxis for the households, treatment support (if required), nutrition support, comorbidity testing and drug susceptibility testing need to be undertaken in order to ensure complete cure. To deliver this, the public health system needs at least the mobile number and residential address of the patient. Moreover, Government of India has recently initiated a scheme which provides the TB patients Rs. 500/- per month for nutrition support through Direct Benefit Transfer (DBT) for the duration of treatment. To provide this support, contact details of TB patients are essential. Mobile number is particularly useful in contacting the patient and informing him before reaching-out to him.

It is difficult to do photocopy of every anti-TB prescription, when electricity is not regular in villages. How to get records of such patients who even bring prescription?

As per the Drug and Cosmetic Rule, 1945, the supply of a drug specified in Schedule H1 shall be recorded in a separate register. Anti-TB drugs have been specified under the Schedule H1. Photograph of prescription can also be taken which later on can be printed or preserved as electronic copy.

How to report on monthly basis from remote villages where there are issues related to internet availability, courier or post services?

Reporting of anti-TB drug sale is desirable to be sent from pharmacies on monthly basis to DTO and Drug Inspector. In case of unavailability of communication measures, public health staff can support collection of such reports in consultation with DTO / Drug inspector.

If Doctor notifies TB patient at the time of prescribing medicine, why are pharmacies asked to provide information?

The Gazette mandates health facility, pharmacy and laboratories to notify each TB patient at the earliest. Accordingly, the health facility/doctor will notify TB patients. But, in case it does not happen, the Government cannot afford to lose any TB patients from being notified, as it is a public health responsibility to prevent the spread of disease in the community. Those health facilities/ doctors who are not notifying TB patients will attract the Gazette provisions and it will be ensured that health facility notifies at diagnosis. Moreover, there are now incentives for notification of TB patient, which will be provided to the provider (doctor / chemist / laboratory) whoever notifies the TB patient.

Do pharmacies have to or don't have to retain the original, or a photocopy of the prescription of the doctor?

As per the Drugs and Cosmetic Act, 1940, it is mandatory for pharmacies to keep a copy of prescription of drugs covered under Schedule H1 in a separate record and such record should be maintained for three years and be available for inspection. As per Drugs and Cosmetic Rules, 1945, the supply of a drug specified under schedule H1 shall be recorded in a separate register at the time of supply, giving name and address of prescriber, the name of patient, the name of drug and the quantity supplied and such record shall be maintained for three years and be open for inspection.

What all information need to be furnished or to be maintained with regards to TB, by the pharmacies?

Annexure III is the TB notification format for pharmacies. It includes information of medical practitioner who prescribed the anti-TB drugs in addition to TB patient's information, diagnosis and drug dispensing information. Details of the drugs prescribed are to be furnished or maintained as per annexure IV in line with Schedule H1 of Drugs and Cosmetic Rules, 1945. This includes dosages, formations (to be read as formulation) and duration of anti-TB drug dispensed for.

Note - As per the Gazette on mandatory notification of Tuberculosis (TB), it is the duty of the registered pharmacies to divulge the information to the authorized notification official as regards TB which is a notifiable disease in the country. It is estimated that a TB patient, if left untreated, can spread the infection to at least 10-15 persons in a year. Hence, in case of TB, the concerned public health authorities should be informed immediately.




The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
Email Address
Company Name
Confirm Password
Mondaq Newsalert
Select Topics
Select Regions
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions